Document Detail


Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
MedLine Citation:
PMID:  17027564     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although polymer coating of coronary stents enables sufficient loading and release of incorporated drugs, it has also been associated with potentially negative effects. This study compared the clinical, angiographic, and intravascular ultrasound (IVUS) outcomes of patients treated with polymer- versus nonpolymer-based paclitaxel-eluting stents (PESs). Sixty-five consecutive patients (70 de novo lesions) treated with polymer-based PESs (TAXUS, 1 microg/mm2 of paclitaxel; Boston Scientific Corp.) and 65 consecutive patients (65 de novo lesions) treated with nonpolymer-based PESs (V-Flex Plus, 2.7 microg/mm2 of paclitaxel; Cook, Inc.) were enrolled in the study. Six-month angiographic follow-up was performed on 54 lesions of the polymer-based PES group and 51 lesions of the nonpolymer-based PES group. IVUS at angiographic follow-up was performed in 61 of the first 70 included lesions. At 6-month IVUS follow-up, mean intimal hyperplasia cross-sectional area was 2.36 +/- 1.60 mm2 in the nonpolymer-based PES group versus 0.62 +/- 0.41 mm2 in the polymer-based PES group (p = 0.003). Implantation of polymer-based PESs resulted in significantly lower in-stent late lumen loss (0.22 +/- 0.27 vs 0.74 +/- 0.61 mm, respectively, p <0.001). In-stent binary restenosis rate was 5% versus 20%, respectively (p <0.001). Target lesion revascularization rate was 9% after implantation of polymer-based PES versus 18% (p = 0.128) after implantation of nonpolymer-based PES, and the major adverse cardiac event rate was 9% versus 23%, respectively (p = 0.032). In conclusion, polymer-based PESs result in superior angiographic and IVUS follow-up findings compared with nonpolymer-based PESs.
Authors:
Ekaterina Iofina; Roswitha Langenberg; Rüdiger Blindt; Harald Kühl; Malte Kelm; Rainer Hoffmann
Related Documents :
20636844 - Aggressive plaque modification with rotational atherectomy and/or cutting balloon befor...
9315574 - Comparison of outcome after stenting for de novo versus restenotic narrowings in native...
15831974 - Expanded applications of rotational atherectomy in contemporary coronary and peripheral...
12565084 - Involvement of c-reactive protein obtained by directional coronary atherectomy in plaqu...
15084554 - Cardiac ecmo for biventricular hearts after paediatric open heart surgery.
8596064 - The discrepancy between echocardiography, cineventriculography and thermodilution. eval...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2006-08-28
Journal Detail:
Title:  The American journal of cardiology     Volume:  98     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-09     Completed Date:  2006-11-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1022-7     Citation Subset:  AIM; IM    
Affiliation:
The Medical Clinic I, University Aachen, Aachen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Angiography
Coronary Stenosis / mortality,  therapy*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Paclitaxel / administration & dosage*
Recurrence
Stents*
Survival Rate
Treatment Outcome
Tubulin Modulators / administration & dosage*
Ultrasonography, Interventional
Chemical
Reg. No./Substance:
0/Tubulin Modulators; 33069-62-4/Paclitaxel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of 30-day outcomes in patients &lt;75 years of age versus >or=75 years of age with acute ...
Next Document:  Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinic...